News Briefs

OncoLens inks $7.25m Series A

OncoLens, a provider of tumor board and cancer treatment planning solutions, has secured $7.25 million in Series A funding.

-

OncoLens, a provider of tumor board and cancer treatment planning solutions, has secured $7.25 million in Series A funding. The investors included BIP Capital, Martin Ventures, and SeedToB Capital.

Source: Press Release